Suchergebnisse - "Fu, Yang-Xin"

PubPharm (576)

1

Intraepithelial lymphocytes promote intestinal regeneration through CD160/HVEM signaling

enthalten in: Mucosal immunology | 2024

von Huang, J. | Zhang, X. | Xu, H. | +9

2

Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer

enthalten in: Oncogene | 2024

von Chen, H. | Lee, L. | Vincent, K. | +8

3

Inactivation of TGF-β signaling in CAR-T cells

enthalten in: Cellular & molecular immunology | 2024

von Yang, Z. | Fu, Y.

4

Promises and challenges of organoids : From humanized to human derived

enthalten in: Cell stem cell | 2024

von Wang, W. | Fu, Y.

CommentOn: Cell Stem Cell. 2024 Mar 7;31(3):410-420.e4. - PMID 38402619

5

Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity

enthalten in: Nature nanotechnology | 2024

von Liu, G. | Ma, N. | Cheng, K. | +13

6

STING licensing of type I dendritic cells potentiates antitumor immunity

enthalten in: Science immunology | 2024

von Wang, J. | Li, S. | Wang, M. | +9

UpdateOf: bioRxiv. 2024 Jan 09;:. - PMID 38260493

7

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

enthalten in: bioRxiv.org | 2024

von Wang, J. | Li, S. | Wang, M. | +9

8

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

enthalten in: bioRxiv : the preprint server for biology | 2024

von Wang, J. | Li, S. | Wang, M. | +9

UpdateIn: Sci Immunol. 2024 Feb 16;9(92):eadj3945. - PMID 38363830

9

Facts and hopes on chimeric cytokine agents for cancer immunotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Ren, Z. | Zhang, X. | Fu, Y.

10

SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-DG, CHECKPOINT INHIBITORS AND RADIATION THERAPY

enthalten in: Europäisches Patentamt | 2023

von SHAY JERRY | FU YANG-XIN | MENDER ILGEN | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[58]